Silkim Pharma Ltd. is a biopharmaceutical company founded in 2013 with a focus on developing novel, first-in-class drugs targeting inflammatory pathologies. The company's key focus lies in leveraging a core technology platform to produce groundbreaking pharmaceutical solutions. With its strong foothold in the biopharma, biotechnology, and life sciences industries, Silkim Pharma Ltd. is positioned as a promising player in the healthcare sector. As of now, details regarding the company's headquarters, last investment, and last investment investors remain undisclosed. With its innovative approach to drug development and targeting of critical medical conditions, Silkim Pharma Ltd. is poised to attract attention from venture capital firms seeking to invest in cutting-edge pharmaceutical advancements.
There is no investment information
No recent news or press coverage available for Silkim Pharma Ltd..